Scitara announces collaboration with PerkinElmer Informatics to create new model of the modern lab

Marlborough, MA – April 14, 2022 – Market leading innovator in laboratory digital transformation, Scitara, has announced a collaboration with scientific analytical technology leader, PerkinElmer. The move will support the integration of the PerkinElmer® Signals Research Suite™ informatics platform, which provides seamless, end-to-end scientific data and workflow management, with laboratory instruments, applications and resources via the... Read more

Molecular Devices continues investment in Organoid Innovation Center adding cell engineering capabilities to automated 3D cell culture platform

Next-gen 3D biology lab programs stem cells that differentiate and self-organize into organoid models with higher reproducibility and consistency for screening San Jose, Calif., April 12, 2022 – Molecular Devices, LLC., a leading provider of high-performance life science solutions, this month celebrates the one-year anniversary of its automated 3D imaging workcell, the Organoid Innovation Center, located at... Read more

Danaher Announces Conversion Date For Series A Mandatory Convertible Preferred Stock

Danaher Announces Conversion Date For Series A Mandatory Convertible Preferred Stock WASHINGTON, April 12, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that its 4.75% Series A Mandatory Convertible Preferred Stock (the “Preferred Stock”), will automatically convert into shares of the Company’s Common Stock on April 15, 2022 (the “Conversion Date”). The conversion rate... Read more